详情页 - 河北大学附属医院知识库

资源类型：

文章类型：

作者：

Wang, Haoqi[1,2,3,4,5,6,7,8,9] * ; Liu, Yueping[1,2,3,4,5,6,7,8,9] ; Yang, Hua[1,2,3,4,5,6,7,8,9]

; Wang, Shuaibing[1,2,3,4,5,6,7,8,9] ; Cui, Guozhong[1,2,3,4,5,6,7,8,9] ; Ma, Jie[1,2,3,4,5,6,7,8,9] ; Liu, Yunjiang[1,2,3,4,5,6,7,8,9] ; Li, Xianqiao[1,2,3,4,5,6,7,8,9] ; Luo, Ruizhen[1,2,3,4,5,6,7,8,9] ; Zhang, Wei[1,2,3,4,5,6,7,8,9] ; Geng, Cuizhi[1,2,3,4,5,6,7,8,9] ;

机构： [1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China [2]Hebei Med Univ, Hosp 4, Dept Pathol, Shijiazhuang, Peoples R China [3]Hebei Univ,Affiliated Hosp,Dept Med Oncol,Baoding,Peoples R China [4]Hebei PetroChina Cent Hosp, Langfang, Peoples R China [5]Cangzhou Cent Hosp, Dept Breast & Thyroid Surg, Cangzhou, Peoples R China [6]Tangshan Peoples Hosp, Tangshan, Peoples R China [7]Hebei Engn Univ, Affiliated Hosp, Handan, Peoples R China [8]Cangzhou Hosp Integrated TCM WM Hebei, Dept Breast Surg, Cangzhou, Peoples R China [9]Hebei Med Univ, Hosp 4, Breast Ctr, Shijiazhuang, Hebei, Peoples R China

出处：

DOI：

ISSN：

语种：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2022]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China [2]Hebei Med Univ, Hosp 4, Dept Pathol, Shijiazhuang, Peoples R China [3]Hebei Univ,Affiliated Hosp,Dept Med Oncol,Baoding,Peoples R China [4]Hebei PetroChina Cent Hosp, Langfang, Peoples R China [5]Cangzhou Cent Hosp, Dept Breast & Thyroid Surg, Cangzhou, Peoples R China [6]Tangshan Peoples Hosp, Tangshan, Peoples R China [7]Hebei Engn Univ, Affiliated Hosp, Handan, Peoples R China [8]Cangzhou Hosp Integrated TCM WM Hebei, Dept Breast Surg, Cangzhou, Peoples R China [9]Hebei Med Univ, Hosp 4, Breast Ctr, Shijiazhuang, Hebei, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Pyrotinib-based therapy for patients with HER2-positive breast cancer: A multicenter, real-world study

文献详情